# 바이오스페이스 일일 뉴스 리포트 - 2025년 09월 16일


## 주요 헤드라인

1. **AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/astrazeneca-suspends-270m-uk-commitment-months-after-scrapping-vaccine-facility>

2. **AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/astrazeneca-suspends-270m-uk-commitment-months-after-scrapping-vaccine-facility>

3. **Rush of Targeted Myasthenia Gravis Therapies Hit Once Sparse Market (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/rush-of-targeted-myasthenia-gravis-therapies-hit-once-sparse-market>

4. **EASD 2025 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/easd-2025-orforglipron-in-focus-the-case-for-cardiovascular-benefits-more>

5. **Novo’s Headcount Rose 81% in Five Years as Revenue Climbed (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novos-headcount-rose-81-in-five-years-as-revenue-climbed>

6. **Novo’s Headcount Rose 81% in Five Years as Revenue Climbed (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novos-headcount-rose-81-in-five-years-as-revenue-climbed>

7. **Beyond MariTide (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/beyond-maritide-amgen-makes-portfolio-play-amid-scrutiny-of-obesity-prospect>


---
*2025년 09월 16일 바이오스페이스 뉴스 피드에서 생성된 리포트*